All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
The present disclosure pertains generally, but not by way of limitation, synthetic eyes for surgical training. More particularly, the present disclosure relates to a realistic synthetic eye that can replicate the visual and tactile feedback of real surgery. Specifically the synthetic eye is designed for training/practice of inserting an implantable device for the treatment of glaucoma.
According to a draft report by The National Eye Institute (NEI) at The United States National Institutes of Health (NIH), glaucoma is now the leading cause of irreversible blindness worldwide and the second leading cause of blindness, behind cataract, in the world. Thus, the NEI draft report concludes, “it is critical that significant emphasis and resources continue to be devoted to determining the pathophysiology and management of this disease.” Glaucoma researchers have found a strong correlation between high intraocular pressure and glaucoma. For this reason, eye care professionals routinely screen patients for glaucoma by measuring intraocular pressure using a device known as a tonometer. Many modern tonometers make this measurement by blowing a sudden puff of air against the outer surface of the eye.
The eye can be conceptualized as a ball filled with fluid. There are two types of fluid inside the eye. The cavity behind the lens is filled with a viscous fluid known as vitreous humor. The cavities in front of the lens are filled with a fluid know as aqueous humor. Whenever a person views an object, he or she is viewing that object through both the vitreous humor and the aqueous humor.
Whenever a person views an object, he or she is also viewing that object through the cornea and the lens of the eye. In order to be transparent, the cornea and the lens can include no blood vessels. Accordingly, no blood flows through the cornea and the lens to provide nutrition to these tissues and to remove wastes from these tissues. Instead, these functions are performed by the aqueous humor. A continuous flow of aqueous humor through the eye provides nutrition to portions of the eye (e.g., the cornea and the lens) that have no blood vessels. This flow of aqueous humor also removes waste from these tissues.
Aqueous humor is produced by an organ known as the ciliary body. The ciliary body includes epithelial cells that continuously secrete aqueous humor. In a healthy eye, a stream of aqueous humor flows out of the anterior chamber of the eye through the trabecular meshwork and into Schlemm's canal as new aqueous humor is secreted by the epithelial cells of the ciliary body. This excess aqueous humor enters the venous blood stream from Schlemm's canal and is carried along with the venous blood leaving the eye.
When the natural drainage mechanisms of the eye stop functioning properly, the pressure inside the eye begins to rise. Researchers have theorized prolonged exposure to high intraocular pressure causes damage to the optic nerve that transmits sensory information from the eye to the brain. This damage to the optic nerve results in loss of peripheral vision. As glaucoma progresses, more and more of the visual field is lost until the patient is completely blind.
Ocular stents, scaffolds, or support structures can be implanted into Schlemm's canal for the purpose of lowering intraocular pressure by facilitating the flow of aqueous humor from the anterior chamber into Schlemm's canal. These ocular implants are typically delivered into Schlemm's canal by inserting a cannula of a delivery system into the anterior chamber of the eye, through the trabecular meshwork, and advancing the implant through the cannula into Schlemm's canal. Upon implantation, the device provides a support structure, serving to dilate and restore the natural aqueous outflow pathway through Schlemm's canal, leading to a reduction of intraocular pressure.
Surgical training for delivery of ocular implants typically requires the use of human cadaver anterior segments. Prospective surgeons can practice delivery of ocular implants through the trabecular meshwork and into Schlemm's canal of eye bank eyes during the wet-lab portion of the training. However, human anterior segments are not easy to obtain, and are costly and difficult to transport and dispose of. Currently existing eye models do not properly replicate the feel and look of a human trabecular meshwork.
A synthetic eye model is provided, comprising a rigid or semi-rigid eye shell, a synthetic iris base positioned within the eye shell, an eye core positioned within the eye shell and encircling the synthetic iris base, the eye core including a channel integral to the eye core configured to replicate Schlemm's canal of a human eye, and a synthetic trabecular meshwork tissue coupled to the eye shell and extending across the channel.
In some embodiments, the synthetic eye further comprises a synthetic cornea disposed over the eye shell.
In one example, the eye core further includes a protrusion adjacent to the channel and being configured to replicate a scleral spur of a human eye. In some implementations, the synthetic trabecular meshwork tissue extends across the protrusion and the channel.
In one embodiment, the synthetic trabecular meshwork comprises a hydrogel-based synthetic tissue.
In other embodiments, the rigid or semi-rigid eye shell includes a corneal portion and a scleral portion.
In some examples, the corneal portion integral to the scleral portion.
In one implementation, the eye core comprises a plurality of eye core pieces.
In another example, the synthetic eye includes one or more internal supports configured to attach to the synthetic trabecular meshwork tissue to prevent the synthetic trabecular meshwork tissue from collapsing into the channel.
In some embodiments, the synthetic eye further comprises a chamber positioned between the eye shell and the synthetic trabecular meshwork tissue.
A method performing surgical training is provided, comprising the steps of inserting an ocular implant into a synthetic eye, the ocular implant comprising an inlet portion at a proximal end and a Schlemm's canal portion disposed distal to the inlet portion, advancing the Schlemm's canal portion of the implant through a synthetic trabecular meshwork tissue, advancing the Schlemm's canal portion of the implant into a channel of the synthetic eye, so that the Schlemm's canal portion tracks the channel as it is advanced, and disposing the inlet portion of the implant in a chamber of the synthetic eye adjacent to the synthetic trabecular meshwork tissue.
A method of deploying an ocular implant into a synthetic eye is provided, comprising piercing a synthetic trabecular meshwork with a distal tip of a delivery tool from within a chamber of the synthetic eye, inserting the distal tip of the delivery tool into a channel of the synthetic eye, and advancing an ocular implant from the delivery tool to place a body portion of the ocular implant in the channel and an inlet portion of the ocular implant in the chamber.
The disclosure may be more completely understood in consideration of the following detailed description of various embodiments in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
The following description should be read with reference to the drawings, which are not necessarily to scale, wherein like reference numerals indicate like elements throughout the several views. The detailed description and drawings are intended to illustrate but not limit the claimed invention. Those skilled in the art will recognize that the various elements described and/or shown may be arranged in various combinations and configurations without departing from the scope of the disclosure. The detailed description and drawings illustrate example embodiments of the claimed invention.
The following detailed description should be read with reference to the drawings, in which similar elements in different drawings are identified with the same reference numbers. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the disclosure.
The challenge with designing a synthetic model of the eye is producing a synthetic trabecular meshwork that properly replicates the feel and look of a human trabecular meshwork. The human trabecular meshwork is a thin delicate structure with membrane like properties. It is fragile and thin, but also stretchy and resilient. The appearance of the trabecular meshwork can vary with pigment amount and location within the angle.
According to the present disclosure, a synthetic eye model includes several design elements. Referring to
The synthetic trabecular meshwork tissue 102 can comprise a synthetic tissue to replicate the feel and appearance of real trabecular meshwork tissue. When the synthetic eye model 100 is fully assembled, the synthetic trabecular meshwork tissue 102 attaches to, connects to, or is stretched or wrapped around the eye core 104. In a real human eye, the trabecular meshwork is an area of tissue in the eye located around the base of the cornea, responsible for draining aqueous humor from the anterior chamber of the eye. A real trabecular meshwork tissue is “spongy” and lined by trabeculocytes which allows fluid drainage. In some examples, the synthetic trabecular meshwork tissue 102 comprises a hydrogel-based synthetic tissue material, such as SynDaver synthetic tissues, called SynTissue®.
In some embodiments, the entire synthetic model of the eye is disposable and is intended for only a limited amount of training sessions. However, in other embodiments, many components of the synthetic eye model 100 are intended to be reused for future training sessions, with components such as the synthetic trabecular meshwork tissue and/or eye core being replaceable within a reusable eye shell. For example, the eye core may be modular within the eye shell, and can be removed when the synthetic trabecular meshwork tissue is in need of replacement. A new synthetic trabecular meshwork tissue may be applied or affixed to the eye core, and re-inserted into the eye shell for additional training sessions.
The eye core 104 includes features that, in combination with the synthetic trabecular meshwork tissue 104, combines to replicate look and feel of anatomical locations in a real eye such as Schlemm's canal. As described above, in a real eye the trabecular meshwork provides for drainage of aqueous humor from the anterior chamber into Schlemm's canal. Thus, in the synthetic eye model 100, the eye core 104 includes a cutout, groove, ridge, or channel that replicates the look and feel of a real Schlemm's canal. The eye core 104, as described above, can be configured to attach or connect to the synthetic trabecular meshwork tissue. In some embodiments, the eye core 104 can include anatomical features to improve the realism of the synthetic eye model. In one example, the eye core 104 can comprise a soft material such as silicon. However, it should be understood that other materials, including materials that mimic the softness, feel, and durability of real human tissues can be used.
The eye core 104 (and 204 in
Referring back to
The iris base 108 is configured to provide a stable base and support for the eye core and also serve as a visual reference for the scleral spur of the eye core 104. The iris base can be manufactured from a synthetic material chosen to imitate the look and/or feel of a real human iris. In one example, the iris base 108 can comprise a soft material such as silicon. The iris base 108 can be shaped and sized to hold or be connected or attached to the eye core 104 and/or the eye shell 106. During surgical training, the iris base can be used as a landmark to help the trainee/surgeon identify the location of the scleral spur.
As shown in both
Referring to
Alternative embodiments of the eye core and synthetic trabecular meshwork tissue are shown in
Referring to
In some examples, the canal or channel portion within the eye core of the synthetic eye representing Schlemm's canal can be dyed to highlight the synthetic trabecular meshwork tissue as a further visual aid for the surgical training. In one embodiment, the canal is dyed with a raw silicone dye that is uncured and injected into the canal after assembly of the synthetic eye model. The uncured silicone dye does not dissipate over time since the hydrogel-based synthetic tissue of the trabecular meshwork only absorbs water, and the silicone of the eye core is hydrophobic. With this dye and method, the silicone dye stays in the canal and the area of tissue over the scleral spur landmark in the eye core remains clear. The synthetic eye model on the left of
In another embodiment a different dye mixture of larger dye particles is suspended in a gel like mixture of propylene glycol, glycerine, and iron oxide. The mixture is unique because the iron oxide particles are large and get stuck in the hydrogel much similar in appearance to a real human trabecular meshwork. Instead of being a solid brown line, the trabecular meshwork looks textured and speckled, making the synthetic tissue look remarkably realistic. Over time the iron oxide particles appear to maintain their position and concentration in the synthetic tissue. The synthetic eye model on the right of
As described above, the synthetic eye model can be used for surgical training to mimic the feel of inserting an ocular implant into Schlemm's canal. In some embodiments, the ocular implant can be sized and shaped to fit within Schlemm's canal (or within the channel of the synthetic eye model). The ocular implant can include a curved body that can be generally tubular in shape and can include one or more openings along its length. In some embodiments, the ocular implant is designed and configured to reside fully within Schlemm's canal (or the synthetic Schlemm's canal). In other embodiments, the ocular implant can include an inlet portion that is designed and configured to extend from Schlemm's canal into the anterior chamber.
The ocular implants used for surgical training with the synthetic eye model typically will require or incorporate a delivery system. The delivery system can be configured to advance the ocular implant into the eye of a patient, or in this case, into the synthetic eye model. Typically, these ocular implant delivery systems will include a cannula configured to house the ocular implant and an advancement system or mechanism configured to push or advance the ocular implant out of the cannula or into the eye (or synthetic eye). In some embodiments, the delivery system can include features that improve the ease of use, including, for example, cutting distal portions on the cannula for insertion into the eye and/or rotation features or curvature designed and configured to facilitate proper orientation with between the cannula and the target tissue (e.g., Schlemm's canal).
Methods of use are also provided herein.
Next, at step 804, the method can include advancing the Schlemm's canal portion of the implant through a synthetic trabecular meshwork tissue. At step 806, the method can include advancing the Schlemm's canal portion of the implant into a channel of the synthetic eye, so that the Schlemm's canal portion tracks the channel as it is advanced. As described above, the synthetic trabecular meshwork tissue can be stretched or extended across a channel of the eye core. In some examples, the synthetic meshwork tissue stretches across a protrusion representing the scleral spur and across the channel.
Finally, at step 806, the method can include disposing the inlet portion of the implant in a chamber of the synthetic eye adjacent to the synthetic trabecular meshwork tissue. As described above, the chamber of the synthetic eye can be designed and configured to represent an anterior chamber of a human eye. In this method, the inlet or proximal portion of the ocular implant is implanted so as to remain within the chamber of the synthetic eye, while the Schlemm's canal or distal portion of the implant is implanted to remain with the channel of the synthetic eye.
At step 904, the method can further include inserting the distal tip of the delivery tool into a channel of the synthetic eye. As described above, the channel of the eye core can be designed and configured to mimic the characteristics and dimensions of a real Schlemm's canal.
Finally, at step 902, the method can include advancing an ocular implant from the delivery tool to place a body portion of the ocular implant in the channel and an inlet portion of the ocular implant in the chamber. As described above, in some embodiments the ocular implant can include an inlet portion designed and configured to remain within the anterior chamber of the eye when the distal or body portion of the implant is inserted into Schlemm's canal, to facilitate the removal of aqueous humor from the anterior chamber.
Definitions of certain terms are provided below and shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same or substantially the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure. Other uses of the term “about” (i.e., in a context other than numeric values) may be assumed to have their ordinary and customary definition(s), as understood from and consistent with the context of the specification, unless otherwise specified.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include or otherwise refer to singular as well as plural referents, unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed to include “and/or,” unless the content clearly dictates otherwise.
It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment(s) described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an embodiment, it would be within the knowledge of one skilled in the art to affect such feature, structure, or characteristic in connection with other embodiments, whether or not explicitly described, unless clearly stated to the contrary. That is, the various individual elements described below, even if not explicitly shown in a particular combination, are nevertheless contemplated as being combinable or able to be arranged with each other to form other additional embodiments or to complement and/or enrich the described embodiment(s), as would be understood by one of ordinary skill in the art.
It is to be understood that even though numerous characteristics of various embodiments have been set forth in the foregoing description, together with details of the structure and function of various embodiments, this detailed description is illustrative only, and changes may be made in detail, especially in matters of structure and arrangements of parts illustrated by the various embodiments to the full extent indicated by the broad general meaning of the terms in which the appended claims are expressed.
This application claims the benefit of priority of U.S. Provisional Application No. 62/902,274, filed Sep. 18, 2019, which is herein incorporated by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2020/051498 | 9/18/2020 | WO |
Number | Date | Country | |
---|---|---|---|
62902274 | Sep 2019 | US |